Last checked at 24 Oct 2013 14:57
24 October 2013
Eco Animal Health Group plc ("Eco" or the "Company")
Scrip Dividend and Issue of Equity
The Company announces that on 25 October 2013, 11,540 new Ordinary shares of 5p each will be issued to shareholders who elected to receive new shares instead of cash for the interim dividend declared by the directors on 11 July 2013 and who held Ordinary shares on the record date of 13 September 2013.
In addition, the Company has been informed that an ex employee has exercised options to purchase 10,000 new ordinary shares of 5p each in the Company at an exercise price of £0.85 per share.
The 21,540 new shares, which will rank pari passu with the existing shares of the Company, are expected to be admitted to trading on 28 October 2013.
Following these issues, the Company has 62,450,931 shares in issue of 5p each, with one voting right per share.
Enquiries:
| ECO Animal Health Group plc | |||
| Peter Lawrence, Executive Chairman | 020 8336 6190 | ||
| Marc Loomes, CEO | 020 8447 8899 | ||
| Spiro Financial | |||
| Anthony Spiro | 020 8336 6196 | ||
| Cenkos Securities plc (Nominated Adviser) | |||
| Stephen Keys | 020 7397 8926 | ||
| Elizabeth Bowman | 020 7397 8928 | ||
ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.
Copyright Business Wire 2013